Balancing Between Concentration and Volume when Developing Patient-Centric Biologics

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/d0/cb/0d/d0cb0de6-ff12-70cd-fba5-6720111b2cf4/mza_5543077143899086824.jpg/600x600bb.jpg

PharmaTalkRadio

Conference Forum

514 episodes

2 days ago

PharmaTalkRadio is an internet radio podcast platform organized and supported by the Conference Forum to give easy and free access to industry professionals, patient advocacy and students in medicine development. PharmaTalkRadio features industry insiders on the latest strategies, business models, and new innovations to advance clinical research with emphasis on clinical trials, patient- centricity, drug delivery, Immuno-oncology, digital, mobile and other technologies as well as leadership topics and emerging biotech challenges. Also featured on PharmaTalkRadio are podcasts covering a wide range of topics from Conference Forum events.

All content for PharmaTalkRadio is the property of Conference Forum and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Balancing Between Concentration and Volume when Developing Patient-Centric Biologics

PharmaTalkRadio

28 minutes

2 months ago

Balancing Between Concentration and Volume when Developing Patient-Centric Biologics

Summary:
When developing patient-centric products for biologics, different doses, expressed by different combinations of volume/concentration may require different delivery devices. As a result, it takes a great deal of time and effort in planning and coordinating the formulation and device activities. In this podcast, Pharma and Drug Delivery executives from Nanoform, Pfizer, GSK, Takeda and Kymanox discuss how they facilitate partnerships between drug product development, device engineering and clinical study teams to determine how to balance concentration and volume and develop optimal devices for delivery and commercialization. Specifically:

Impact on increasing concentration of drugs on deliverability
Technical feasibility of manufacturing larger volume devices
Patient tolerability and human factors that impact patient adherence

This panel discussion was recorded at the October 2024 PODD: Partnership Opportunities in Drug Delivery conference. For more information, go to Drug-Delivery.org.